Chromium supplementation improves glucose tolerance in diabetic Goto-Kakizaki rats

IUBMB Life

Volumn 60, Issue 8, 2008, Pages 541-548

  Abdourahman, Aicha ^a   Edwards, John G ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Chromium picolinate; Dietary supplements; Glucose tolerance; Goto Kakizaki; NIDDM; Type 2 diabetes

Indexed keywords

CHROMIUM PICOLINATE; PICOLINIC ACID; PICOLINIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; GLYCEMIC CONTROL; GOTO KAKIZAKI RAT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT; SUPPLEMENTATION; TREATMENT OUTCOME; WISTAR RAT; ANALYSIS OF VARIANCE; ANIMAL; COMPARATIVE STUDY; DIET SUPPLEMENTATION; GLUCOSE INTOLERANCE; RAT STRAIN;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

ANALYSIS OF VARIANCE; ANIMALS; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; PICOLINIC ACIDS; RATS; RATS, MUTANT STRAINS;

EID: 52049099639     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.84     Document Type: Article

References (62)

1. Ryan, G. J., Wanko, N. S., Redman, A. R., and Cook, C. B. (2003) Chromium as adjunctive treatment for type 2 diabetes. Ann. Pharmacother. 37, 876-885.
2. Bagchi, D., Stohs, S. J., Downs, B. W., Bagchi, M., and Preuss, H. G. (2002) Cytotoxicity and oxidative mechanisms of different forms of chromium. Toxicology 180, 5-22. (Pubitemid 35248089)
3. Sugiyama, M. (1992) Role of physiological antioxidants in chromium(VI)-induced cellular injury. Free Radic. Biol. Med. 12, 397-407.
4. Jeejeebhoy, K. N., Chu, R. C., Marliss, E. B., Greenberg, G. R., and Bruce-Robertson, A. (1977) Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition. Am. J. Clin. Nutr. 30, 531-538.
5. Cheng, H. H., Lai, M. H., Hou, W. C., and Huang, C. L. (2004) Antioxidant effects of chromium supplementation with type 2 diabetes mellitus and euglycemic subjects. J. Agric. Food Chem. 52, 1385-1389.
6. Schroeder, H. A. (1965) Diabetic-like serum glucose levels in chromium deficient rats. Life Sci. 4, 2057-2062.
7. Brown, R. O., Forloines-Lynn, S., Cross, R. E., and Heizer, W. D. (1986) Chromium deficiency after long-term total parenteral nutrition. Dig. Dis. Sci. 31, 661-664.
8. Anderson, R. A. (1998) Chromium, glucose intolerance and diabetes. J. Am. Coll. Nutr. 17, 548-555.
9. Hambidge, K. M., Rodgerson, D. O., and O'Brien, D. (1968) Concentration of chromium in the hair of normal children and children with juvenile diabetes mellitus. Diabetes 17, 517-519.
10. Morris, B. W., MacNeil, S., Hardisty, C. A, Heller, S., Burgin, C., and Gray, T. A. (1999) Chromium homeostasis in patients with type II (NIDDM) diabetes. J. Trace Elem. Med. Biol. 13, 57-61.
11. Mita, Y., Ishihara, K., Fukuchi, Y., Fukuya, Y., and Yasumoto, K. (2005) Supplementation with chromium picolinate recovers renal Cr concentration and improves carbohydrate metabolism and renal function in type 2 diabetic mice. Biol. Trace Elem. Res. 105, 229-248.
12. Sun, Y., Clodfelder, B. J., Shute, A. A., Irvin, T., and Vincent, J. B. (2002) The biomimetic [Cr(3)O(O(2)CCH(2)CH(3))(6)(H(2)O)(3)](+) decreases plasma insulin, cholesterol, and triglycerides in healthy and type II diabetic rats but not type I diabetic rats. J. Biol. Inorg. Chem. 7, 852-862.
13. Raz, I. and Havivi, E. (1988) Influence of chronic diabetes on tissue and blood cells status of zinc, copper, and chromium in the rat. Diabetes Res. 7, 19-23.
14. Long-Ying, Z., Zi-Rong, X., Min-Qi, M., and Liang-Ying, G. (2007) Effects of chromium nanoparticle dosage on growth, body composition, serum hormones, and tissue chromium in Sprague-Dawley rats. J. Zhejiang Univ. Sci. 8, 323-330.
15. Anderson, R. A., Bryden, N. A., and Polansky, M. M. (1997) Lack of toxicity of chromium chloride and chromium picolinate in rats. J. Am. Coll. Nutr. 16, 273-279.
16. Anderson, R. A., Polansky, M. M., Bryden, N. A., Bhathena, S. J., and Canary, J. J. (1987) Effects of supplemental chromium on patients with symptoms of reactive hypoglycemia. Metabolism 36, 351-355.
17. Davis, C. M. and Vincent, J. B. (1997) Chromium oligopeptide activates insulin receptor tyrosine kinase activity. Biochemistry 36, 4382-4385. (Pubitemid 27180283)
18. Ghosh, D., Bhattacharya, B., Mukherjee, B., Manna, B., Sinha, M., Chowdhury, J., and Chowdhury, S. (2002) Role of chromium supplementation in Indians with type 2 diabetes mellitus. J. Nutr. Biochem. 13, 690-697.
19. Bahijiri, S. M., Mira, S. A., Mufti, A. M., and Ajabnoor, M. A. (2000) The effects of inorganic chromium and brewer's yeast supplementation on glucose tolerance, serum lipids and drug dosage in individuals with type 2 diabetes. Saudi Med. J. 21, 831-837.
20. Althuis, M. D., Jordan, N. E., Ludington, E. A., and Wittes, J. T. (2002) Glucose and insulin responses to dietary chromium supplements: a meta-analysis. Am. J. Clin. Nutr. 76, 148-155.
21. Yasuda, K., Nishikawa, W., Iwanaka, N., Nakamura, E., Seino, Y., Tsuda, K., and Ishihara, A. (2002) Abnormality in fibre type distribution of soleus and plantaris muscles in non-obese diabetic Goto-Kakizaki rats. Clin. Exp. Pharmacol. Physiol. 29, 1001-1008.
22. Yagihashi, S., Goto, Y., Kakizaki, M., and Kaseda, N. (1978) Thickening of glomerular basement membrane in spontaneously diabetic rats. Diabetologia 15, 309-312. (Pubitemid 9096509)
23. Goto, Y., Kakizaki, M., and Masaki, N. (1976) Production of a spontaneous diabetic rats by repetition of selective breeding. Tohoku J. Exp. Med. 119, 85-90.
24. Portha, B., Serradas, P., Bailbe, D., Suzuki, K., Goto, Y., and Giroix, M. H. (1991) Beta-cell insensitivity to glucose in the GK rat, a spontaneous nonobese model for type II diabetes. Diabetes 40, 486-491.
25. Witte, K., Jacke, K., Stahrenberg, R., Arlt, G., Reitenbach, I., Schilling, L., and Lemmer, B. (2002) Dysfunction of soluble guanylyl cyclase in aorta and kidney of Goto-Kakizaki rats: influence of age and diabetic state. Nitric Oxide 6, 85-95. (Pubitemid 34848269)
26. Murakawa, Y., Zhang, W., Pierson, C. R., Brismar, T., Ostenson, C. G., Efendic, S., and Sima, A. A. (2002) Impaired glucose tolerance and insulinopenia in the GK-rat causes peripheral neuropathy. Diabetes Metab. Res. Rev. 18, 473-483.
27. Janssen, U., Riley, S. G., Vassiliadou, A., Floege, J., and Phillips, A. O. (2003) Hypertension superimposed on type II diabetes in Goto Kakizaki rats induces progressive nephropathy. Kidney Int. 63, 2162-2170. (Pubitemid 36605827)
28. Phillips, A. O., Baboolal, K., Riley, S., Grone, H., Janssen, U., Steadman, R., Williams, J., and Floege, J. (2001) Association of prolonged hyperglycemia with glomerular hypertrophy and renal basement membrane thickening in the Goto Kakizaki model of non-insulin-dependent diabetes mellitus. Am. J. Kidney Dis. 37, 400-410.
29. Yagihashi, S., Kaseda, N., Kakizaki, M., and Goto Y. (1979) Evolution of glomerular lesions in rats with spontaneous diabetes. Tohoku J. Exp. Med. 127, 359-367.
30. Yagihashi, S., Tonosaki, A., Yamada, K., Kakizaki, M., and Goto, Y. (1982) Peripheral neuropathy in selectively-inbred spontaneously diabetic rats: electrophysiological, morphometrical and freeze-replica studies. Tohoku J. Exp. Med. 138, 39-48.
31. Vesely, D. L., Gower, W. R, Jr., Dietz, J. R., Overton, R. M., Clark, L. C., Antwi, E. K., and Farese, R. V. (1999) Elevated atrial natriuretic peptides and early renal failure in type 2 diabetic Goto-Kakizaki rats. Metabolism 48, 771-778.
32. Santos, D. L., Palmeira, C. M., Seica, R., Dias, J., Mesquita, J., Moreno, A. J., and Santos, M. S. (2003) Diabetes and mitochondrial oxidative stress: a study using heart mitochondria from the diabetic Goto-Kakizaki rat. Mol. Cell Biochem. 246, 163-170.
33. Santos, M. S., Santos, D. L., Palmeira, C. M., Seica, R., Moreno, A. J., and Oliveira, C. R. (2001) Brain and liver mitochondria isolated from diabetic Goto-Kakizaki rats show different susceptibility to induced oxidative stress. Diabetes Metab. Res. Rev. 17, 223-230.
34. Oliveira, P. J., Rolo, A. P., Seica, R., Palmeira, C. M., Santos, M. S., and Moreno, A. J. (2001) Decreased susceptibility of heart mitochondria from diabetic GK rats to mitochondrial permeability transition induced by calcium phosphate. Biosci. Rep. 21, 45-53.
35. Palmeira, C. M., Ferreira, F. M., Santos, D. L., Ceica, R., Suzuki, K., and Santos, M. S. (1999) Higher efficiency of the liver phosphorylative system in diabetic Goto-Kakizaki (GK) rats. FEBS Lett. 458, 103-106. (Pubitemid 29428163)
36. Ferreira, F. M., Palmeira, C. M., Matos, M. J., Seica, R., and Santos, M. S. (1999) Decreased susceptibility to lipid peroxidation of Goto-Kakizaki rats: relationship to mitochondrial antioxidant capacity. Life Sci. 65, 1013-1025.
37. Oliveira, P. J., Rolo, A. P., Seica, R., Sardao, V., Monteiro, P., Goncalves, L., Providencia, L., Palmeira, C. M., Santos, M. S., and Moreno, A. J. (2002) Impact of diabetes on induction of the mitochondrial permeability transition. Rev. Port Cardiol. 21, 759-766.
38. Anderson, R. A., Cheng, N., Bryden, N. A., Polansky, M. M., Chi, J., and Feng, J. (1997) Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes 46, 1786-1791. (Pubitemid 27456412)
39. Kim, D. S., Kim, T. W., and Kang, J. S. (2004) Chromium picolinate supplementation improves insulin sensitivity in Goto-Kakizaki diabetic rats. J Trace Elem. Med. Biol. 17, 243-247.
40. Matsuda, M. and DeFronzo, R. A. (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22, 1462-1470. (Pubitemid 29418240)
41. Martin, J., Wang, Z. Q., Zhang, X. H., Wachtel, D., Volaufova, J., Matthews, D. E., and Cefalu, W. T. (2006) Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes. Diabetes Care 29, 1826-1832. (Pubitemid 44156637)
42. Rucker, R. and Storms, D. (2002) Interspecies comparisons of micronutrient requirements: metabolic vs. absolute body size. J. Nutr. 132, 2999-3000.
43. Freireich, E. J., Gehan, E. A., Rall, D. P., Schmidt, L. H., and Skipper, H. E. (1966) Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother. Rep. 50, 219-244.
44. Mordenti, J. (1986) Man versus beast: pharmacokinetic scaling in mammals. J. Pharm. Sci. 75, 1028-1040.
45. Tipton, C. M., Barnard, R. J., and Tcheng, T. K. (1969) Resting heart rate investigations with trained and nontrained hypophysectomized rats. J. Appl. Physiol. 26, 585-588.
46. Barnard, R. J., Corre, K., and Cho, H. (1976) Effect of training on the resting heart rate of rats. Eur. J. Appl. Physiol. Occup. Physiol. 35, 285-289.
47. Mordenti, J. (1986) Dosage regimen design for pharmaceutical studies conducted in animals. J. Pharm. Sci. 75, 852-857.
48. Bedford, T., Tipton, C., and Wilson, N. (1979) Maximum oxygen consumption of rats and its changes with various experimental procedures. J. Appl. Physiol. 47, 1278-1283.
49. 3]+ increases insulin sensitivity and improves blood plasma variables in healthy and type 2 diabetic rats. J. Biol. Inorg. Chem. 10, 119-130.
50. Cefalu, W. T., Wang, Z. Q., Zhang, X. H., Baldor, L. C., and Russell, J. C. (2002) Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats. J. Nutr. 132, 1107-1114.
51. Rodrigues, S. F., de Oliveira, M. A., Martins, J. O., Sannomiya, P., de Cassia Tostes, R., Nigro, D., Carvalho, M. H., and Fortes, Z. B. (2006) Differential effects of chloral hydrate- and ketamine/xylazine-induced anesthesia by the s.c. route. Life Sci. 79, 1630-1637. (Pubitemid 44344729)
52. Brown, E. T., Umino, Y., Loi, T., Solessio, E., and Barlow, R. (2005) Anesthesia can cause sustained hyperglycemia in C57/BL6J mice. Vis. Neurosci. 22, 615-618.
53. Saha, J. K., Xia, J., Grondin, J. M., Engle, S. K., and Jakubowski, J. A. (2005) Acute hyperglycemia induced by ketamine/xylazine anesthesia in rats: mechanisms and implications for preclinical models. Exp. Biol. Med. (Maywood) 230, 777-784.
54. Hallmark, M. A., Reynolds, T. H., DeSouza, C. A., Dotson, C. O., Anderson, R. A., and Rogers, M. A. (1996) Effects of chromium and resistive training on muscle strength and body composition. Med. Sci. Sports Exerc. 28, 139-144.
55. Lukaski, H. C., Bolonchuk, W. W., Siders, W. A., and Milne, D. B. (1996) Chromium supplementation and resistance training: effects on body composition, strength, and trace element status of men. Am. J Food Chem. Toxicol. Clin. Nutr. 63, 954-965.
56. Campbell, W. W., Joseph, L. J., Anderson, R. A., Davey, S. L., Hinton, J., and Evans, W. J. (2002) Effects of resistive training and chromium picolinate on body composition and skeletal muscle size in older women. Int. J. Sport Nutr. Exerc. Metab. 12, 125-135.
57. Rhodes, M. C., Hebert, C. D., Herbert, R. A., Morinello, E. J., Roycroft, J. H., Travlos, G. S., and Abdo, K. M. (2005) Absence of toxic effects in F344/N rats and B6C3F1 mice following subchronic administration of chromium picolinate monohydrate. Food Chem. Toxicol. 43, 21-29.
58. Miranda, E. R. and Dey, C. S. (2004) Effect of chromium and zinc on insulin signaling in skeletal muscle cells. Biol. Trace Elem. Res. 101, 19-36.
59. Vincent, J. B. (1999) Mechanisms of chromium action: low-molecular-weight chromium-binding substance. J. Am. Coll. Nutr. 18, 6-12.
60. Chen, G., Liu, P., Pattar, G. R., Tackett, L., Bhonagiri, P., Strawbridge, A. B., and Elmendorf, J. S. (2006) Chromium activates glucose transporter 4 trafficking and enhances insulin-stimulated glucose transport in 3T3-L1 adipocytes via a cholesterol-dependent mechanism. Mol. Endocrinol. 20, 857-870.
61. Brautigan, D. L., Kruszewski, A., and Wang, H. (2006) Chromium and vanadate combination increases insulin-induced glucose uptake by 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 347, 769-773.
62. Giroix, M. H., Vesco, L., and Portha, B. (1993) Functional and metabolic perturbations in isolated pancreatic islets from the GK rat, a genetic model of noninsulin-dependent diabetes. Endocrinology 132, 815-822. (Pubitemid 23056144)